The plasma proteomics data showed that 7 of 8 DEPs involved in platelet degranulation (APOH, CAP1, F13A1, ITIH3, QSOX1, SPP2, THBS1, and VWF) were downregulated in lean NAFLD patients. The gene discussed is F13A1; the disease is metabolic dysfunction-associated steatotic liver disease.